The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development

Molecular and Cellular Biology

Volumn 28, Issue 1, 2008, Pages 282-292

  Beliakoff, Jason ^a   Lee, Jane ^a   Ueno, Hiroo ^a   Aiyer, Aparna ^b   Weissman, Irving L ^a   Barsh, Gregory S ^a   Cardiff, Robert D ^c   Sun, Zijie ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN ZIMP10; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG;

ALLELE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE DISRUPTION; GENETIC TRANSCRIPTION; HOMOZYGOSITY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOLK SAC;

ANIMALS; CELLS, CULTURED; EMBRYO LOSS; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIESIS; HOMOZYGOTE; HUMANS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PROTO-ONCOGENE PROTEINS C-FOS; TRANSCRIPTION FACTORS; YOLK SAC;

MUS;

EID: 37549060391     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00771-07     Document Type: Article

References (39)

1. Adiseshaiah, P., S. R. Papaiahgari, H. Vuong, D. V. Kalvakolanu, and S. P. Reddy. 2003. Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells. J. Biol. Chem. 278:47423-17433.
2. Battle, T. E., R. A. Lynch, and D. A. Frank. 2006. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res. 66:3649-3657.
3. Beliakoff, J., and Z. Sun. 2006. Zimp7 and Zimp10, two novel PIAS-like proteins, function as androgen receptor coregulators. Nucl. Recept. Signal. 4:e017.
4. Escalante-Alcalde, D., L. Hernandez, H. Le Stunff, R. Maeda, H. S. Lee, C. Gang, Jr., V. A. Sciorra, I. Daar, S. Spiegel, A. J. Morris, and C. L. Stewart. 2003. The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development 130:4623-4637.
5. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan, and M. W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
6. Fischer, A., N. Schumacher, M. Maier, M. Sendtner, and M. Gessler. 2004. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18:901-911.
7. Gale, N. W., M. G. Dominguez, I. Noguera, L. Pan, V. Hughes, D. M. Valenzuela, A. J. Murphy, N. C. Adams, H. C. Lin, J. Holash, G. Thurston, and G. D. Yancopoulos. 2004. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 101:15949-15954.
8. Gutiérrez, L., M. Zurita, J. A. Kennison, and M. Vazquez. 2003. The Drosophila trithorax group gene tonalli (tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING finger protein. Development 130:343-354.
9. Huang, C. Y., J. Beliakoff, X. Li, J. Lee, X. Li, M. Sharma, B. Lim, and Z. Sun. 2005. hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol. Endocrinol. 19:2915-2929.
10. Iso, T., Y. Hamamori, and L. Kedes. 2003. Notch signaling in vascular development. Arterioscler. Thromb. Vasc. Biol. 23:543-553.
11. Jackson, P. K. 2001. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053-3058.
12. Kahyo, T., T. Nishida, and H. Yasuda. 2001. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8:713-718.
13. Kawai-Kowase, K., M. S. Kumar, M. H. Hoofnagle, T. Yoshida, and G. K. Owens. 2005. PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol. Cell. Biol. 25:8009-8023.
14. Kotaja, N., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2002. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J. Biol. Chem. 277:30283-30288.
15. Kotaja, N., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2002. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22:5222-5234.
16. Kotaja, N., M. Vihinen, J. J. Palvimo, and O. A. Janne. 2002. Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J. Biol. Chem. 277:17781-17788.
17. Krebs, L. T., J. R. Shutter, K. Tanigaki, T. Honjo, K. L. Stark, and T. Gridley. 2004. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18:2469-2473.
18. Larsson, J., M. J. Goumans, L. J. Sjostrand, M. A. van Rooijen, D. Ward, P. Leveen, X. Xu, P. ten Dijke, C. L. Mummery, and S. Karlsson. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20:1663-1673.
19. Lee, J., J. Beliakoff, and Z. Sun. 2007. The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res. 35:4523-4534.
20. Li, T. H., H. Zhao, Y. Peng, J. Beliakoff, J. D. Brooks, and Z. Sun. 2007. A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Res. 35:2767-2776.
21. Li, X., G. Thyssen, J. Beliakoff, and Z. Sun. 2006. The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J. Biol. Chem. 281:23748-23756.
22. Liu, B., S. Mink, K. A. Wong, N. Stein, C. Getman, P. W. Dempsey, H. Wu, and K. Shuai. 2004. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol. 5:891-898.
23. Long, J., I. Matsuura, D. He, G. Wang, K. Shuai, and F. Liu. 2003. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc. Natl. Acad. Sci. USA 100:9791-9796.
24. Long, J., G. Wang, I. Matsuura, D. He, and F. Liu. 2004. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). Proc. Natl. Acad. Sci. USA 101:99-104.
25. Megidish, T., J. H. Xu, and C. W. Xu. 2002. Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). J. Biol. Chem. 277:8255-8259.
26. Miyazono, K., S. Maeda, and T. Imamura. 2005. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16:251-263.
27. Nagy, A., M. Gersenstein, K. Vintersten, and R. Behringer. 2003. Manipulating the mouse embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
28. Nishida, T., and H. Yasuda. 2002. PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277:41311-41317.
29. Oettgen, P. 2001. Transcriptional regulation of vascular development. Circ. Res. 89:380-388.
30. Pfeifer, A., T. Kessler, S. Silletti, D. A. Cheresh, and I. M. Verma. 2000. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc. Natl. Acad. Sci. USA 97: 12227-12232.
31. Santti, H., L. Mikkonen, A. Anand, S. Hirvonen-Santti, J. Toppari, M. Panhuysen, F. Vauti, M. Perera, G. Corte, W. Wurst, O. A. Janne, and J. J. Palvimo. 2005. Disruption of the murine PIASx gene results in reduced testis weight. J. Mol. Endocrinol. 34:645-654.
32. Schmidt, D., and S. Muller. 2003. PIAS/SUMO: new partners in transcriptional regulation. Cell Mol. Life Sci. 60:2561-2574.
33. Schreiber, M., Z. Q. Wang, W. Jochum, I. Fetka, C. Elliott, and E. F. Wagner. 2000. Placental vascularisation requires the AP-1 component fra1. Development 127:4937-4948.
34. Sharma, M., X. Li, Y. Wang, M. Zarnegar, C. Y. Huang, J. J. Palvimo, B. Lim, and Z. Sun. 2003. hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J. 22:6101-6114.
35. Urness, L. D., L. K. Sorensen, and D. Y. Li. 2000. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat. Genet. 26:328-331.
36. Verras, M., J. Brown, X. Li, R. Nusse, and Z. Sun. 2004. Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res. 64:8860-8866.
37. Wong, K. A., R. Kim, H. Christofk, J. Gao, G. Lawson, and H. Wu. 2004. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol. Cell. Biol. 24:5577-5586.
38. Wu, L., H. Wu, L. Ma, F. Sangiorgi, N. Wu, J. R. Bell, G. E. Lyons, and R. Maxson. 1997. Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Dev. 65:3-17.
39. Young, M. R., and N. H. Colburn. 2006. Fra-1 a target for cancer prevention or intervention. Gene 379:1-11.